Dr. Clyde E. Markowitz, MD

Dr. Markowitz practices at Perelman Center For Advanced Medicine in Philadelphia, Pennsylvania.

Dr. Markowitz's NPI, 1417981135, was assigned on July 10, 2006. Dr. Markowitz graduated from Columbia University College of Physicians and Surgeons in 1990. Dr. Markowitz holds Pennsylvania license MD066765L.

Dr. Markowitz's primary practice is Perelman Center for Advanced Medicine, at 3400 Civic Center Blvd Fl 2 Fl 2, Philadelphia, PA 19104. The practice phone is (215) 615-4949.

Dr. Markowitz's primary practice is Perelman Center For Advanced Medicine in Philadelphia, Pennsylvania. Dr. Markowitz is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Markowitz to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Markowitz practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Markowitz's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Markowitz is licensed in Pennsylvania.

CMS data shows 587 Medicare services from Dr. Markowitz across 5 procedure codes in 2024, for 248 Medicare patients. Medicare paid $30,224 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 248 Medicare patients who saw Dr. Markowitz in 2024. The largest group is 65 to 74, with 137 patients. 69% of them have high cholesterol, and 54% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Markowitz's median patient age at 58, with 70% women.

In 2024, Dr. Markowitz wrote 1,227 Medicare Part D claims for 156 patients. 55% of them were for generic drugs. CMS names the drug for 1,084 of them, across 21 drugs with 11 or more claims each, at $4,495,811 in total drug cost. In 2023, CMS named 1,105 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Markowitz for performance year 2024, reported as part of a group. Dr. Markowitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 27 papers to Dr. Markowitz, published from 2010 to 2025. 2014 was the busiest year, with 4. The most frequent topics are Multiple Sclerosis, Magnetic Resonance Imaging and Brain. Dr. Markowitz has published most often in Mult Scler. Dr. Markowitz's most frequent co-authors are Erica Berlin Baller, Joseph Rossi Berger, MD and Theodore D. Satterthwaite, MD.

Dmand AI links Dr. Markowitz to 1 clinical trial. Conditions studied include Multiple Sclerosis, Relapsing-Remitting and Multiple Sclerosis.

CMS Open Payments shows 566 general payments to Dr. Markowitz from 25 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 72% of the total. Genentech, Inc. paid the most, $140,818. It also lists 2 research payments totaling $1,839 from 2018 to 2020.

Dr. Markowitz graduated from Columbia University College of Physicians and Surgeons in 1990.